Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2016 2
2017 2
2018 3
2019 4
2020 10
2021 6
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19).
Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY, Wong HM, Tern PJW, Chandran M, Chay JWM, Nagarajan C, Sultana R, Low JGH, Ng HJ. Tan CW, et al. Among authors: nagarajan c. Nutrition. 2020 Nov-Dec;79-80:111017. doi: 10.1016/j.nut.2020.111017. Epub 2020 Sep 8. Nutrition. 2020. PMID: 33039952 Free PMC article. Clinical Trial.
BCMA-targeting approaches for treatment of multiple myeloma.
Chen Y, Nagarajan C, Tan MS, Martinelli G, Cerchione C. Chen Y, et al. Among authors: nagarajan c. Panminerva Med. 2021 Mar;63(1):28-36. doi: 10.23736/S0031-0808.20.04121-X. Epub 2020 Sep 21. Panminerva Med. 2021. PMID: 32955181 Free article. Review.
No association between <i>ECSIT</i> germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma.
Ong SY, Lim JQ, Grigoropoulos N, Laurensia Y, Huang D, Chia BKH, Zhe DCM, Saraf SA, Cheng CL, Chuang WY, Kuo MC, Su YJ, Phipps C, Nagarajan C, Lee YS, Lung DTC, Shih LY, Goh YT, Lim ST, Ong CK. Ong SY, et al. Among authors: nagarajan c. Haematologica. 2021 Jun 1;106(6):1737-1739. doi: 10.3324/haematol.2020.269209. Haematologica. 2021. PMID: 33054138 Free PMC article. No abstract available.
Pleural plasmacytomas - the role of radiotherapy.
Yeoh KW, Thitsar SM, Master Z, Loh Y, Chen Y, Nagarajan C, Tin KM, Cutter D, Mikhaeel G. Yeoh KW, et al. Among authors: nagarajan c. Br J Haematol. 2020 Aug;190(3):e160-e162. doi: 10.1111/bjh.16770. Epub 2020 Jun 10. Br J Haematol. 2020. PMID: 32519756 No abstract available.
A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1).
Chen Y, Gopalakrishnan SK, Ooi M, Sultana R, Lim LH, Grigoropoulos N, Ong SY, Xu M; SGHMM1 Investigators, Chng WJ, Goh YT, Nagarajan C. Chen Y, et al. Among authors: nagarajan c. Blood Cancer J. 2021 Sep 3;11(9):150. doi: 10.1038/s41408-021-00544-x. Blood Cancer J. 2021. PMID: 34480015 Free PMC article. Clinical Trial. No abstract available.
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
Kizhakeyil A, Zaini NBM, Poh ZS, Wong BHS, Loh X, Ng AS, Low ZS, Prasannan P, Gong C, Tan MGK, Nagarajan C, Huang D, Lu PW, Lim JQ, Barrans S, Ong CK, Lim ST, Chng WJ, Follows G, Hodson DJ, Du MQ, Goh YT, Tan SH, Grigoropoulos NF, Verma NK. Kizhakeyil A, et al. Among authors: nagarajan c. Mol Cancer. 2021 Oct 16;20(1):134. doi: 10.1186/s12943-021-01437-0. Mol Cancer. 2021. PMID: 34654425 Free PMC article. No abstract available.
28 results